Skip to main content

COMMENTARY

Int J Public Health, 31 October 2022

Considering How Best to Allocate Limited Resources for Healthcare in Lower-Income Settings–Reflections on Ghanaian Community-Led Data Collection

O. K. Afreh&#x;O. K. Afreh1P. Angwaawie&#x;P. Angwaawie2J. K. E. Attivor&#x;J. K. E. Attivor2L. A. Boateng&#x;L. A. Boateng3K. Brackstone&#x;K. Brackstone3M. G. Head
&#x;M. G. Head3*A. K. Manyeh&#x;A. K. Manyeh4G. A. A. Vidzro&#x;G. A. A. Vidzro2
  • 1Regional Health Directorate, Ghana Health Services, Accra, Ghana
  • 2Nkwanta South Municipal Health Directorate, Ghana Health Services, Accra, Ghana
  • 3Clinical Informatics Research Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
  • 4Institute of Health Research, University of Health and Allied Sciences, Ho, Ghana

As the world begins to transition beyond the urgent phase of the pandemic response, countries are increasingly looking to “mainstream” their COVID-19 management comprising of vaccination and case management into routine healthcare. Access to routine healthcare was severely limited across much of 2020 and 2021, with the greatest impact noted in lower-income settings [1].

Population health undoubtedly has been negatively impacted, and countries are even more unlikely to reach Sustainable Development Goal targets by 2030. Policymakers, therefore, need up-to-date evidence to plan healthcare delivery and direct their limited resources toward priority areas. One effective, but resource-intensive, approach to disease control is Mass Drug Administration (MDA). An MDA is where preventive chemotherapy is used as a strategic approach to treat populations at risk of infection, with medicines being distributed across communities [2]. These form a core component of the 2021–2030 WHO Neglected Tropical Diseases (NTDs) Roadmap [3]. The WHO targets for MDAs typically require greater than 80% uptake to be considered effective with disease control [4]. With a community-wide intervention such as an MDA, local acceptance is vital to ensuring high engagement.

Ghana is a lower-middle income country in West Africa with approximately 30 million people. Like many countries in sub-Saharan Africa, Ghana has used MDAs successfully to control diseases such as onchocerciasis and lymphatic filariasis [4]. During the COVID-19 pandemic, and following WHO guidance, MDAs mostly did not take place in Ghana.

There are ongoing research partnerships between the Ghana Health Service, the University for Health and Allied Sciences (Ghana), and the University of Southampton (UK). These include the Oti Regional Health Directorate and Nkwanta South Municipality (a rural area close to the Togo border) (Figure 1).

FIGURE 1
www.frontiersin.org

FIGURE 1. Map illustrating Ghana and the location of Nkwanta South municipality (Oti region, Ghana, 2022).

In January 2022, a research survey took place around community viewpoints on the pandemic response and COVID-19 vaccination [5]. Alongside this, a small number of supplementary questions were asked around knowledge, acceptance and value of MDAs to manage NTDs. The previous MDA in these communities took place in the last quarter of 2019, distributing ivermectin as a means to control (in particular) onchocerciasis. Onchocerciasis is a mosquito-driven NTD prevalent in parts of Ghana.

Survey data was collected on electronic devices, using Kobo Toolbox platform, by 47 residents, known as Community-Based Surveillance Volunteers (CBSVs). This is similar to the methods used to distribute medicines during an MDA, albeit data collection that is usually paper-based. The survey was carried out in three hard-to-reach sub-municipalities within Nkwanta South, specifically Alokpatsa (population of 11,028), Brewaniase (14,483), and Tutukpene (15,453). A total of 1,370 responses were received.

One question asked covered whether the individual perceived benefits from the MDA to their household or community, and 98.2% of respondents suggested they did perceive benefits. Only 578 people (44.3%) correctly recalled that the MDA took place more than 2 years ago, but respondents overwhelmingly understood the reasons why such programs are used. For example, 745 people (55.1%) correctly indicated that managing onchocerciasis may reduce the risk of blindness (a known consequence of the infection). Another 596 (44.1%) responded that the MDA would promote general good health. Finally, most respondents were knowledgeable that the program used community volunteers (98.7%) and that the activity was led by the Ghana Health Service (97.2%). The small number of complaints from the survey respondents about the previous MDA overwhelmingly focused on the possibility of being left out (e.g., household missed the exercise or was not registered, n = 136, or a medicine shortage, n = 31) rather than aspects around their inclusion.

Thus, on the whole, this survey indicated good community recall, knowledge and acceptance of the value of an MDA. Knowing that there is strong evidence that such an intervention is generally well received among these communities is useful for Ghanaian policymakers when planning future health services.

Neighbourhood viewpoints or acceptance prior to the pandemic may be affected or unaffected in the years to come. However, there are concerns that misinformation can become embedded within vulnerable communities, for example around the misuse of ivermectin during the pandemic as a treatment for COVID-19, which has been problematic for public health teams in South America and South-East Asia [6].

Rollouts of health programs such as MDAs can be financially costly and involves significant person-time. Training community volunteers to collect electronic data around knowledge and local viewpoints may be a useful, economical and sustainable approach to inform likely acceptance and be a guide to uptake. It is important to consider community viewpoints on NTDs and other areas of health across other areas of Ghana, plus in other sub-Saharan countries.

Author Contributions

MH drafted the first version of this article. All co-authors reviewed and provided comments. All authors approved the submission.

Funding

This work received financial support from the Coalition for Operational Research on Neglected Tropical Diseases, which is funded at the Task Force for Global Health primarily by the Bill & Melinda Gates Foundation, by the United States Agency for International Development through its Neglected Tropical Diseases Program, and with UK aid from the British people (OPP1053230).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

1.World Health Organization. Pulse Survey on Continuity of Essential Health Services during the COVID-19 Pandemic: Interim Report [Internet] (2020). Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-EHS_continuity-survey-2020.1 (Accessed October 25, 2022).

Google Scholar

2. Webster, JP, Molyneux, DH, Hotez, PJ, and Fenwick, A. The Contribution of Mass Drug Administration to Global Health: Past, Present and Future. Philos Trans R Soc Lond B Biol Sci (2014) 369(1645):20130434. doi:10.1098/rstb.2013.0434

PubMed Abstract | CrossRef Full Text | Google Scholar

3.World Health Organisation. Ending the Neglect to Attain the Sustainable Development Goals: A Road Map for Neglected Tropical Diseases 2021–2030 [Internet]. Geneva (2020). Available at: https://www.who.int/neglected_diseases/Ending-the-neglect-to-attain-the-SDGs--NTD-Roadmap.pdf (Accessed October 25, 2022).

Google Scholar

4. Manyeh, A, Ibisomi, L, Ramaswamy, R, Baiden, F, and Chirwa, T. Exploring Factors Affecting Quality Implementation of Lymphatic Filariasis Mass Drug Administration in Bole and Central Gonja Districts in Northern Ghana. Plos Negl Trop Dis (2020) 15(4):e0007009. doi:10.1371/journal.pntd.0007009

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Brackstone, K, Attivor, EJK, Boateng, LA, Head, M, Manyeh, AK, Vidzro, GAA, et al. Examining Predictors of Vaccine Uptake and Hesitancy in Three Rural Sub-municipalities in Nkwanta South, Oti Region, Ghana [Internet]. Figshare (2022). Available at: /articles/preprint/Examining_predictors_of_vaccine_uptake_and_hesitancy_in_three_rural_sub-municipalities_in_Nkwanta_South_Oti_region_Ghana/19360988/1 (Accessed October 25, 2022).

Google Scholar

6. Alvarez-Moreno, C, Cassell, JA, Donkor, CM, Head, MG, Middleton, J, Pomat, W, et al. Long-term Consequences of the Misuse of Ivermectin Data. Lancet Infect Dis 21:1624–6. doi:10.1016/S1473-3099(21)00630-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: survey research, community health, neglected tropical diseases, Ghana, NTD

Citation: Afreh OK, Angwaawie P, Attivor JKE, Boateng LA, Brackstone K, Head MG, Manyeh AK and Vidzro GAA (2022) Considering How Best to Allocate Limited Resources for Healthcare in Lower-Income Settings–Reflections on Ghanaian Community-Led Data Collection. Int J Public Health 67:1605434. doi: 10.3389/ijph.2022.1605434

Received: 27 September 2022; Accepted: 19 October 2022;
Published: 31 October 2022.

Edited by:

Nino Kuenzli, Swiss Tropical and Public Health Institute (Swiss TPH), Switzerland

Copyright © 2022 Afreh, Angwaawie, Attivor, Boateng, Brackstone, Head, Manyeh and Vidzro. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: M. G. Head, m.head@soton.ac.uk

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.